APA (7th ed.) Citation

Merx, K., Müller, M. C., Kreil, S., Lahaye, T., Paschka, P., Schoch, C., . . . Hochhaus, A. (2002). Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α. Leukemia, 16(9), . https://doi.org/10.1038/sj.leu.2402680

Chicago Style (17th ed.) Citation

Merx, Kirsten, et al. "Early Reduction of BCR-ABL MRNA Transcript Levels Predicts Cytogenetic Response in Chronic Phase CML Patients Treated with Imatinib After Failure of Interferon α." Leukemia 16, no. 9 (2002). https://doi.org/10.1038/sj.leu.2402680.

MLA (9th ed.) Citation

Merx, Kirsten, et al. "Early Reduction of BCR-ABL MRNA Transcript Levels Predicts Cytogenetic Response in Chronic Phase CML Patients Treated with Imatinib After Failure of Interferon α." Leukemia, vol. 16, no. 9, 2002, https://doi.org/10.1038/sj.leu.2402680.